By integrating mechanistic insights with therapeutic perspectives, this review underscores the gut microbiota as a modifiable factor in neuropsychiatric and neurodegenerative disease
Results Baseline characteristics We identified 42,816 subjects treated with metformin in combination with either GLP-1 RAs (n = 16,723) or DPP-4is (n = 26,093)
Immunhistochemical analysis For cFOS analysis, mice were treated s.c
By staying informed, maintaining rigorous standards, and prioritizing safety, health professionals can effectively support clients navigating this exciting frontier of metabolic medicine
The breadth of retatrutides effects reflects something we see every day: when metabolic health improves, almost everything else follows
Is it better to use Taurine and L-Carnitine together